Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan/Prednisone/Thalidomide vs Melphalan/Prednisone/Placebo in Previously Untreated Multiple Myeloma
NCT00218855Phase 3Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Jan 2002
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by Norwegian University of Science and Technology. Started Jan 2002; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00218855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218855.